Clinical Trial Update: Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF) [Phase 1]

View source ↗

Summary

Phase 1 trial update of autologous stem cell therapy aimed at promoting cardiac angiogenesis in ischemic cardiomyopathy; study status is completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• Autologous stem cell therapy for cardiac angiogenesis

Snippet

Sponsor: Texas Heart Institute | Conditions: Ischemic Cardiomyopathy | Phase 1 | Status: COMPLETED | Results posted: 2013-01-30